Data / Form D filings / Skye Bioscience, Inc.
Skye Bioscience, Inc.: Form D filings
Skye Bioscience, Inc., a biotechnology company in San Diego, CA, filed 17 Form D notices with the SEC between 2011 and 2024. The latest, on March 27, 2024, reports $40 million sold of a $40 million offering to 13 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 11250 EL CAMINO REAL, SUITE 100, San Diego, CA, 92130
- Phone
- (858) 410-0266
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Nevada
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1516551
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 27, 2024 | New notice | $40,000,000 | $40,000,000 | 13 | Mar 13, 2024 | sec.gov | |
| Feb 12, 2024 | New notice | $49,991,010 | $49,991,010 | 11 | Jan 31, 2024 | sec.gov | |
| Aug 29, 2023 | New notice | $62,254,435 | $62,254,435 | 12 | Aug 15, 2023 | sec.gov | |
| Nov 15, 2018 | New notice | $32,500,000 | $2,000,000 | $30,500,000 | 1 | Nov 1, 2018 | sec.gov |
| Feb 23, 2018 | Amendment | $8,570,000 | $4,150,000 | $4,420,000 | 2 | Jan 18, 2018 | sec.gov |
| Jan 25, 2018 | New notice | $6,800,000 | $2,400,000 | $4,400,000 | 1 | Jan 18, 2018 | sec.gov |
| Nov 14, 2017 | New notice | $2,000,000 | $2,000,000 | 2 | Nov 1, 2017 | sec.gov | |
| Jan 13, 2017 | New notice | $1,500,000 | $1,200,000 | $300,000 | 5 | Jan 3, 2017 | sec.gov |
| Nov 3, 2016 | New notice | $500,000 | $500,000 | 1 | Oct 26, 2016 | sec.gov | |
| Aug 27, 2015 | New notice | $5,000,000 | $5,000,000 | 15 | Aug 20, 2015 | sec.gov | |
| Apr 15, 2015 | New notice | $2,500,000 | $625,000 | $1,875,000 | 5 | Apr 1, 2015 | sec.gov |
| Jan 9, 2015 | New notice | $724,989 | $724,989 | 7 | Jan 7, 2015 | sec.gov | |
| Nov 13, 2014 | New notice | Indefinite | $0 | 43 | Oct 31, 2014 | sec.gov | |
| Jan 22, 2013 | Amendment | $24,800 | $24,800 | 13 | Nov 8, 2012 | sec.gov | |
| Nov 8, 2012 | New notice | Indefinite | $0 | 0 | Yet to occur | sec.gov | |
| Nov 7, 2012 | Amendment | $9,000 | $9,000 | 7 | Mar 25, 2011 | sec.gov | |
| Mar 25, 2011 | New notice | Indefinite | $0 | 0 | Yet to occur | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Margaret Dalesandro | Director | |
| Punit Dhillon | Executive Officer, Director | |
| Kaitlyn Arsenault | Executive Officer | |
| Annalisa Jenkins | Director | |
| Praveen Tyle | Director | |
| Deborah Charych | Director | |
| Paul Grayson | Director | |
| Andrew Schwab | Director | |
| Keith Ward | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Mar 25, 2024 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Skye Bioscience, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.